FAQ Library - Emerging Therapeutics

What is the CyBorD regimen's safety and efficacy as a primary therapy?
Robert Z. Orlowski, MD, PhD
FAQ Library published on May 9, 2013 in Induction Therapy, Emerging Therapeutics
Dr. Robert Orlowski explains the CyBorD regimen and its safety and efficacy as an induction therapy.
Read More
Are multi-agent therapies more effective than single and double therapies?
George Somlo, MD, FACP
FAQ Library published on January 24, 2012 in Emerging Therapeutics
Dr. Somlo discusses the effectiveness of multi-agents therapies versus the single, double, and triple therapies.
Read More

Results 1 - 2 of 2

MediCom Worldwide, Inc. Links